Atossa Therapeutics, Inc. (ATOS)
4.86
+0.14
(+2.97%)
USD |
NASDAQ |
Mar 04, 16:00
4.86
0.00 (0.00%)
After-Hours: 16:05
Atossa Therapeutics Cash from Investing (Quarterly) : -0.007M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 55.42M |
| Plus Therapeutics, Inc. | 1.297M |
| Abeona Therapeutics, Inc. | -64.63M |
| Cell Source, Inc. | 0.00 |
| Kiora Pharmaceuticals, Inc. | 5.741M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.005M |
| Free Cash Flow | -26.29M |
| Free Cash Flow Per Share (Quarterly) | -0.6981 |
| Free Cash Flow to Equity (Quarterly) | -6.012M |
| Free Cash Flow to Firm (Quarterly) | -6.012M |
| Free Cash Flow Yield | -13.97% |